These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients. Lou Y; Ma Y; Sun J; Ye X; Pan H; Wang Y; Qian W; Meng H; Mai W; He J; Tong H; Jin J Ann Hematol; 2015 Nov; 94(11):1829-37. PubMed ID: 26294332 [TBL] [Abstract][Full Text] [Related]
8. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia. Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384 [TBL] [Abstract][Full Text] [Related]
9. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA. Keeshan K; Vieugué P; Chaudhury S; Rishi L; Gaillard C; Liang L; Garcia E; Nakamura T; Omidvar N; Kogan SC Haematologica; 2016 Oct; 101(10):1228-1236. PubMed ID: 27390356 [TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Chim CS; Wong SY; Pang A; Chu P; Lau JS; Wong KF; Kwong YL Leukemia; 2005 Dec; 19(12):2241-6. PubMed ID: 16239915 [TBL] [Abstract][Full Text] [Related]
11. Therapy-induced PML/RARA proteolysis and acute promyelocytic leukemia cure. Nasr R; Lallemand-Breitenbach V; Zhu J; Guillemin MC; de Thé H Clin Cancer Res; 2009 Oct; 15(20):6321-6. PubMed ID: 19808868 [TBL] [Abstract][Full Text] [Related]
12. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction]. Lang L; Li HM; Liu H; Wang YM; Zhang XM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789 [TBL] [Abstract][Full Text] [Related]
13. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia. Rusiniak ME; Yu M; Ross DT; Tolhurst EC; Slack JL Cancer Res; 2000 Apr; 60(7):1824-9. PubMed ID: 10766166 [TBL] [Abstract][Full Text] [Related]
14. The genomic landscape of core-binding factor acute myeloid leukemias. Faber ZJ; Chen X; Gedman AL; Boggs K; Cheng J; Ma J; Radtke I; Chao JR; Walsh MP; Song G; Andersson AK; Dang J; Dong L; Liu Y; Huether R; Cai Z; Mulder H; Wu G; Edmonson M; Rusch M; Qu C; Li Y; Vadodaria B; Wang J; Hedlund E; Cao X; Yergeau D; Nakitandwe J; Pounds SB; Shurtleff S; Fulton RS; Fulton LL; Easton J; Parganas E; Pui CH; Rubnitz JE; Ding L; Mardis ER; Wilson RK; Gruber TA; Mullighan CG; Schlenk RF; Paschka P; Döhner K; Döhner H; Bullinger L; Zhang J; Klco JM; Downing JR Nat Genet; 2016 Dec; 48(12):1551-1556. PubMed ID: 27798625 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia. Chen Z; Tong Y; Li Y; Gao Q; Wang Q; Fu C; Xia Z PLoS One; 2015; 10(3):e0122530. PubMed ID: 25815789 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL. Leiva M; Moretti S; Soilihi H; Pallavicini I; Peres L; Mercurio C; Dal Zuffo R; Minucci S; de Thé H Leukemia; 2012 Jul; 26(7):1630-7. PubMed ID: 22333881 [TBL] [Abstract][Full Text] [Related]
17. PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity. Noguera NI; Piredda ML; Taulli R; Catalano G; Angelini G; Gaur G; Nervi C; Voso MT; Lunardi A; Pandolfi PP; Lo-Coco F Oncotarget; 2016 Oct; 7(41):66386-66397. PubMed ID: 27626703 [TBL] [Abstract][Full Text] [Related]
18. Transcription and methylation analyses of preleukemic promyelocytes indicate a dual role for PML/RARA in leukemia initiation. Gaillard C; Tokuyasu TA; Rosen G; Sotzen J; Vitaliano-Prunier A; Roy R; Passegué E; de Thé H; Figueroa ME; Kogan SC Haematologica; 2015 Aug; 100(8):1064-75. PubMed ID: 26088929 [TBL] [Abstract][Full Text] [Related]
19. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3. Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355 [TBL] [Abstract][Full Text] [Related]
20. PML-RARA fusion resulting from a cryptic insertion of RARA gene into PML gene without the reciprocal RARA-PML fusion: clinical, cytogenetic, and molecular characterization and prognosis. Fan H; Ortega V; Fanasch HM; Wang Y; Holder KN; Higgins RA; Mendiola C; Mohamed G; Vadlamudi K; Velagaleti G Eur J Haematol; 2014 Oct; 93(4):354-8. PubMed ID: 24673420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]